Key insights across demyelinating and neuroimmunologic disorders, including NMOSD and multiple sclerosis, with a focus on evolving treatment strategies, disease burden, and personalized care approaches.
Q1 Neurology Awareness Highlights
Emerging perspectives in rare neurologic disorders, including multiple system atrophy and broader rare disease awareness initiatives, highlighting advances in diagnosis, biomarkers, and therapeutic development.
Clinical insights and awareness-driven discussions in epilepsy care, including efforts to address treatment gaps, reduce stigma, and improve patient outcomes.
Perspectives on health equity and representation in neurology, including discussions on disparities in care, diversity in leadership, and awareness initiatives shaping the future of clinical practice.
Updates in neuromuscular disease, including Duchenne muscular dystrophy, with a focus on pipeline developments and emerging therapeutic approaches.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Clears Investigational New Drug Application for Remyelinating Agent PTD802 in Multiple Sclerosis
2
Insights on Vibrance-2 Study Results of Alixorexton in Narcolepsy Type 2: Richard K. Bogan, MD, FCCP, FAASM
3
Pipeline Review: Alzheimer Disease Therapies by Mechanism of Action
4
FDA and EMA Accepts Regulatory Applications for Cemdisiran in Generalized Myasthenia Gravis
5